1. Ilott I, Rick J, Patterson M, Turgoose C, Lacey A. What is protocol-based care? A concept analysis. J Nurs Manag. 2006;14(7):544-52. doi: 10.1111/j.1365-2934.2006.00703.x.
2. Gulwani S. Programming by examples: Applications, algorithms, and ambiguity resolution.Redmond, WA: Microsoft Corporation; 2016.
3. Hurst JW, Morris DC, Alexander RW. The use of the New york heart association’s classification of cardiovascular disease as part of the patient’s complete problem list. Clin Cardiol. 1999;22(6):385-90. doi: 10.1002/clc.4960220604.
4. Jun GT, Ward J, Morris Z, Clarkson J. Health care process modelling: which method when? Int J Qual Heal Care. 2009; 21(3):214–24. doi: 10.1093/intqhc/mzp016.
5. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. doi: 10.1136/bmj.n71.
6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 14 2016;37(27):2129-200. doi: 10.1093/eurheartj/ehw128.
7. Ezekowitz JA, O’Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, et al. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017;33(11):1342-433. doi: 10.1016/j.cjca.2017.08.022.
8. Mcmurray JJV, Adamopoulos S, Anker SD, AurFCChio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-847. doi: 10.1093/eurheartj/ehs104.
9. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi: 10.1093/eurheartj/ehab368.
10. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A-13A. doi: 10.1016/0735-1097(93)90455-a.
11. Gómez E. Capítulo 2. Introducción, epidemiología de la falla cardiaca e historia de las clínicas de falla cardiaca en Colombia. Revista Colombiana de Cardiología. 2016;23(Supplement 1):6-12. doi: 10.1016/j.rccar.2016.01.004.
12. Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, Kizer JR, et al. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. JACC: Heart Fail. 2018;6(8):678-85. doi: 10.1016/j.jchf.2018.03.006.
13. Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016 Jun;18(6):613-25. doi: 10.1002/ejhf.566.
14. Brouwers MC, Kerkvliet K, Spithof K. The AGREE reporting checklist: A tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152. doi:10.1136/bmj.i1152.
15. Grupo de trabajo de la Guía de Práctica Clínica sobre Tratamiento de la Falla Cardiaca Crónica. Guía de Práctica Clínica sobre Tratamiento de la Falla Cardiaca Crónica. [cited April 17 2022] Ministerio de Sanidad, Servicios Sociales e Igualdad. Unidad de Evaluación de Tecnologías Sanitarias de la Comunidad de Madrid. 2016;214. Available from: https://bit.ly/3kHAW0J.
16. Colombia. Ministerio de Salud y Protección Social (Minsalud). Guía de práctica clínica para la prevención, diagnóstico, tratamiento y rehabilitación de la falla cardíaca en población mayor de 18 años, clasificación B, C y D. Guía Completa No. 53. Bogotá D.C.: Minsalud; 2016.
17. United Kingdom. National Institute for Health and Care Excellence (NICE). Chronic heart failure in adults: diagnosis and management. NICE guideline. London: NICE; 2018.
18. Scotland. Scottish Intercollegiate Guidelines Network (SIGN). Cardiac Rehabilitation: A national clinical guideline. Edinburg: SIGN. 2017.
19. Scotland. Scottish Intercollegiate Guidelines Network (SIGN). Management of chronic heart failure: A national clinical guideline. Edinburg: SIGN; 2016.
20. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509.
21. Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, Hopper I, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart Lung Circ. 2018;27(10):1123-1208. doi: 10.1016/j.hlc.2018.06.1042.
22. Ezekowitz JA, O’Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, et al. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017;33(11):1342-1433. doi: 10.1016/j.cjca.2017.08.022.
23. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail. junio de 2005; 7(4):537-41. doi: 10.1016/j.ejheart.2005.01.022.
24. Kim DK, Hunter P. Recommended adult immunization schedule, United States, 2019. Ann Intern Med. 2019; 170:182–92. doi: 10.7326/M18-3600.
25. López-Jiménez F, Pérez-Terzic C, Zeballos PC, Anchique CV, Burdiat G, González K, et al. Consenso de Rehabilitación Cardiovascular y Prevención Secundaria de las Sociedades Interamericana y Sudamericana de Cardiología. R Rev.Urug.Cardiol. 2013;28(2):189-224.
26. Bozkurt B, Fonarow GC, Goldberg LR, Guglin M, Josephson RA, Forman DE, et al. Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel. J Am Coll Cardiol. 2021;77(11):1454-69. doi: 10.1016/j.jacc.2021.01.030.
27. Chun K, Kang S-M. Cardiac Rehabilitation in Heart Failure. Int J Heart Fail. 2021;3(1):1-14. doi: 10.36628/ijhf.2020.0021.
28. Liguori G. ACSM’s Guidelines for Exercise Testing and Prescription. 11th ed. Indianapolis, IN: American College of Sports Medicine; 2021.
29. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461. doi: 10.1056/NEJMoa2107038.